NCT05410379View on ClinicalTrials.gov

Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2023

Conditions
Atrial Fibrillation (AF)
Trial Locations (1)

48033

MCH, Cotignola

All Listed Sponsors
lead

Maria Cecilia Hospital

OTHER

NCT05410379 - Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop | Biotech Hunter | Biotech Hunter